← Back to Search

Behavioural Intervention

High-resistance inspiratory muscle strength training for Obesity

N/A
Recruiting
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Body mass index 30 - 40 kg/m2
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 16 weeks
Awards & highlights

Study Summary

This trial aims to find out if training the muscles used for breathing can help lower blood pressure in adults who are overweight.

Who is the study for?
This trial is for adults with obesity, defined by a body mass index (BMI) between 30 and 40 kg/m2. It's not specified who can't join the trial beyond these criteria.Check my eligibility
What is being tested?
The study is testing two types of breathing exercises: one with high resistance and another with very low resistance, to see if they can lower blood pressure in obese adults.See study design
What are the potential side effects?
Potential side effects are not detailed, but inspiratory muscle training may cause temporary breathlessness or fatigue during exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in laboratory-measured blood pressure
Secondary outcome measures
Blood pressure during respiratory muscle testing
Change in ambulatory blood pressure
Change in blood pressure reactivity during aerobic exercise
+1 more
Other outcome measures
Adherence
Change in blood pressure reactivity during handgrip exercise
Change in muscle sympathetic nerve activity (MSNA) and sympathetic transduction
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: High-resistance inspiratory muscle strength trainingActive Control1 Intervention
Participants will perform high-resistance inspiratory muscle strength training on a daily basis for eight weeks using a handheld device that produces resistance that increases the effort of breathing in.
Group II: Very-low resistance inspiratory muscle strength trainingPlacebo Group1 Intervention
Participants will perform very-low-resistance inspiratory muscle strength training on a daily basis for eight weeks using a handheld device that produces resistance that increases the effort of breathing in.

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
200 Previous Clinical Trials
31,714 Total Patients Enrolled
16 Trials studying Obesity
1,374 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being recruited for this ongoing medical study?

"Indeed, clinicaltrials.gov indicates that this trial is actively seeking participants. The initial posting of the trial took place on December 7th, 2023, and the most recent update occurred on January 24th, 2024."

Answered by AI

What are the eligibility criteria for individuals who can participate in this medical research study?

"The objective of this medical trial is to recruit 44 individuals, aged between 20 and 45 years old, who are currently diagnosed with obesity. It is crucial for potential participants to satisfy the following requirements: a body mass index (BMI) falling within the range of 30-40 kg/m2."

Answered by AI

What is the upper limit on the number of individuals involved in this research endeavor?

"Indeed, as indicated by the information provided on clinicaltrials.gov, this study is currently in the process of seeking suitable candidates. The trial was initially posted on December 7th, 2023 and last revised on January 24th, 2024. A total of 44 participants are being sought at a single location."

Answered by AI

Is there an age restriction regarding participation in this medical study, particularly for individuals who have surpassed the milestone of 50 years?

"Patients within the age range of 20 to 45 years old are eligible for participation in this clinical trial."

Answered by AI
~29 spots leftby Jun 2027